Descrizione Clinica
Anti-inflammatory Cerulisina gtt oto fl 20ml Cerulisina
CERULISINA 4,6G /100 ML + 87 G/100 ML AURICULAR GOCCE
active ingredients
1 ml contains: • active ingredients: dimethylbenzene 46 mg, sweet almond oil 870 mg.Excellent
Not presentTherapeutic indications
For the dissolution of cerume and epidermal plugs. In cleaning medicines of operating cavities resulting in interventions in the middle ear.Contraindications
§ Hypersensitivity to active ingredients. § Middle ear diseases (otites, perforated tympane).Population
Population The usual dose is equal to the content of the dropper. For hard caps, the istillations run 2-3 times a day and the treatment goes on for 3-5 days in relation to the amount of cerums to be extracted. Do not exceed the recommended doses. Method of administration Topical use. The content of a dropper, better if intiepidito, is poured, after tilting the head, in the ear canal. The subject must remain for 5-10 minutes in this position. Afterwards, wash the ear with warm water.Conservation
None.Warnings
The use of the medicinal product does not involve any particular precauzioni.Non use in perforated tympane cases. The use, especially if prolonged, of the medicinal product can give rise to phenomena of sensitization. Where this occurs interrupt treatment and establish suitable therapy. Do not use the medicine after the expiry date indicated on the package. Communicate the occurrence of any unwanted effects not described in the leaflet, see paragraph 4.8.Interactions
No interaction between CERULISINA and other drugs.Effects
Prolonged use of CERULISINA can cause awareness. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.aifa.gov.it/content/segnalazioni-reazioni-avverse.Overdosing
No overdose cases have been reported.No known harmful effects on normal therapeutic doses.
Source: Farmadati
